{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T04:03:20Z","timestamp":1743912200804,"version":"3.40.3"},"reference-count":35,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2025,3,31]]},"DOI":"10.1536\/ihj.24-646","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T22:14:32Z","timestamp":1741990472000},"page":"241-251","source":"Crossref","is-referenced-by-count":0,"title":["A Practical Scoring System for Estimating Ventricular Arrhythmia Events in Patients with Cardiac Resynchronization Therapy for Primary Prevention"],"prefix":"10.1536","volume":"66","author":[{"given":"Takayuki","family":"Goto","sequence":"first","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuya","family":"Inden","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yanagisawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Tsurumi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiichi","family":"Miyamae","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Miyazawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Tachi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Iwawaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Hiramatsu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Shimojo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiomi","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"doi-asserted-by":"crossref","unstructured":"1. Stevenson WG, Sweeney MO. Arrhythmias and sudden death in heart failure. Jpn Circ J 1997; 61: 727-40.","key":"1","DOI":"10.1253\/jcj.61.727"},{"doi-asserted-by":"crossref","unstructured":"2. Shen L, Jhund PS, Petrie MC, <i>et al<\/i>. Declining Risk of Sudden Death in Heart Failure. N Engl J Med 2017; 377: 41-51.","key":"2","DOI":"10.1056\/NEJMoa1609758"},{"doi-asserted-by":"crossref","unstructured":"3. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-83.","key":"3","DOI":"10.1056\/NEJM199711273372202"},{"doi-asserted-by":"crossref","unstructured":"4. Moss AJ, Zareba W, Hall WJ, <i>et al<\/i>. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.","key":"4","DOI":"10.1056\/NEJMoa013474"},{"doi-asserted-by":"crossref","unstructured":"5. Kadish A, Dyer A, Daubert JP, <i>et al<\/i>. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-8.","key":"5","DOI":"10.1056\/NEJMoa033088"},{"doi-asserted-by":"crossref","unstructured":"6. K\u00f8ber L, Thune JJ, Nielsen JC, <i>et al<\/i>. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med 2016; 375: 1221-30.","key":"6","DOI":"10.1056\/NEJMoa1608029"},{"doi-asserted-by":"crossref","unstructured":"7. Cazeau S, Leclercq C, Lavergne T, <i>et al<\/i>. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-80.","key":"7","DOI":"10.1056\/NEJM200103223441202"},{"doi-asserted-by":"crossref","unstructured":"8. Abraham WT, Fisher WG, Smith AL, <i>et al<\/i>. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-53.","key":"8","DOI":"10.1056\/NEJMoa013168"},{"doi-asserted-by":"publisher","unstructured":"9. Ruwald MH, Solomon SD, Foster E, <i>et al<\/i>. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Circulation 2014; 130: 2278-86.","key":"9","DOI":"10.1161\/CIRCULATIONAHA.114.011283"},{"doi-asserted-by":"crossref","unstructured":"10. Barra S, Provid\u00eancia R, Boveda S, <i>et al<\/i>. Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention. Heart 2018; 104: 1529-35.","key":"10","DOI":"10.1136\/heartjnl-2017-312546"},{"doi-asserted-by":"crossref","unstructured":"11. Woods B, Hawkins N, Mealing S, <i>et al<\/i>. Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart 2015; 101: 1800-6.","key":"11","DOI":"10.1136\/heartjnl-2015-307634"},{"doi-asserted-by":"crossref","unstructured":"12. Veres B, Feh\u00e9rv\u00e1ri P, Engh MA, <i>et al<\/i>. Time-trend treatment effect of cardiac resynchronization therapy with or without defibrillator on mortality: a systematic review and meta-analysis. Europace 2023; 25.","key":"12","DOI":"10.1093\/europace\/euad289"},{"doi-asserted-by":"crossref","unstructured":"13. Hadwiger M, Dagres N, Haug J, <i>et al<\/i>. Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project. Eur Heart J 2022; 43: 2591-9.","key":"13","DOI":"10.1093\/eurheartj\/ehac053"},{"doi-asserted-by":"crossref","unstructured":"14. Nogami A, Kurita T, Abe H, <i>et al<\/i>. JCS\/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. J Arrhythm 2021; 37: 709-870.","key":"14","DOI":"10.1002\/joa3.12491"},{"doi-asserted-by":"crossref","unstructured":"15. Glikson M, Nielsen JC, Kronborg MB, <i>et al<\/i>. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2021; 42: 3427-520.","key":"15","DOI":"10.1093\/eurheartj\/ehab699"},{"doi-asserted-by":"crossref","unstructured":"16. Tsurumi N, Inden Y, Yanagisawa S, <i>et al<\/i>. Clinical outcomes and predictors of delayed echocardiographic response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2024; 35: 97-110.","key":"16","DOI":"10.1111\/jce.16125"},{"doi-asserted-by":"crossref","unstructured":"17. Okajima T, Inden Y, Yanagisawa S, <i>et al<\/i>. Impact of synchronized left ventricular pacing rate on risk for ventricular tachyarrhythmias after cardiac resynchronization therapy in patients with heart failure. J Interv Card Electrophysiol 2022; 65: 239-49.","key":"17","DOI":"10.1007\/s10840-022-01284-z"},{"doi-asserted-by":"publisher","unstructured":"18. Evans WJ, Morley JE, Argil\u00e9s J, <i>et al<\/i>. Cachexia: a new definition. Clinical nutrition (Edinburgh, Scotland) 2008; 27: 793-9.","key":"18","DOI":"10.1016\/j.clnu.2008.06.013"},{"doi-asserted-by":"publisher","unstructured":"19. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney international 2024; 105: S117-314.","key":"19","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"20","doi-asserted-by":"crossref","first-page":"37073","DOI":"10.1038\/srep37073","volume":"6","year":"2016","unstructured":"20. Fukuda H, Suwa H, Nakano A, <i>et al<\/i>. Non-linear Equation using Plasma Brain Natriuretic Peptide Levels to Predict Cardiovascular Outcomes in Patients with Heart Failure. Scientific reports 2016; 6: 37073.","journal-title":"Scientific Reports","ISSN":"https:\/\/id.crossref.org\/issn\/2045-2322","issn-type":"print"},{"doi-asserted-by":"crossref","unstructured":"21. Younis A, Goldberger JJ, Kutyifa V, <i>et al<\/i>. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score. Eur Heart J 2021; 42: 1676-84.","key":"21","DOI":"10.1093\/eurheartj\/ehaa1057"},{"doi-asserted-by":"crossref","unstructured":"22. Bristow MR, Saxon LA, Boehmer J, <i>et al<\/i>. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-50.","key":"22","DOI":"10.1056\/NEJMoa032423"},{"doi-asserted-by":"crossref","unstructured":"23. Doran B, Mei C, Varosy PD, <i>et al<\/i>. The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy. JACC Heart Fail 2021; 9: 439-49.","key":"23","DOI":"10.1016\/j.jchf.2021.02.013"},{"doi-asserted-by":"crossref","unstructured":"24. Aktas MK, Goldenberg I, Moss AJ, <i>et al<\/i>. Comparison of age (&lt;75 Years versus \u226575 Years) to risk of ventricular tachyarrhythmias and implantable cardioverter defibrillator shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Am J Cardiol 2014; 114: 1855-60.","key":"24","DOI":"10.1016\/j.amjcard.2014.09.026"},{"doi-asserted-by":"crossref","unstructured":"25. Martens P, Verbrugge FH, Nijst P, Dupont M, Mullens W. Mode of Death in Octogenarians Treated With Cardiac Resynchronization Therapy. J Card Fail 2016; 22: 970-7.","key":"25","DOI":"10.1016\/j.cardfail.2016.09.023"},{"doi-asserted-by":"crossref","unstructured":"26. Alvarez CK, Cronin E, Baker WL, Kluger J. Heart failure as a substrate and trigger for ventricular tachycardia. J Interv Card Electrophysiol 2019; 56: 229-47.","key":"26","DOI":"10.1007\/s10840-019-00623-x"},{"doi-asserted-by":"crossref","unstructured":"27. Reiter MJ, Stromberg KD, Whitman TA, Adamson PB, Benditt DG, Gold MR. Influence of intracardiac pressure on spontaneous ventricular arrhythmias in patients with systolic heart failure: insights from the REDUCEhf trial. Circ Arrhythm Electrophysiol 2013; 6: 272-8.","key":"27","DOI":"10.1161\/CIRCEP.113.000223"},{"doi-asserted-by":"crossref","unstructured":"28. Tsutsui H, Isobe M, Ito H, <i>et al<\/i>. JCS 2017\/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure - Digest Version. Circ J 2019; 83: 2084-184.","key":"28","DOI":"10.1253\/circj.CJ-19-0342"},{"doi-asserted-by":"publisher","unstructured":"29. Gheorghiade M, Konstam MA, Burnett JC Jr., <i>et al<\/i>. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 2007; 297: 1332-43.","key":"29","DOI":"10.1001\/jama.297.12.1332"},{"doi-asserted-by":"crossref","unstructured":"30. Konstam MA, Kiernan M, Chandler A, <i>et al<\/i>. Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload. J Am Coll Cardiol 2017; 69: 1409-19.","key":"30","DOI":"10.1016\/j.jacc.2016.12.035"},{"doi-asserted-by":"crossref","unstructured":"31. Moss AJ, Hall WJ, Cannom DS, <i>et al<\/i>. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-40.","key":"31","DOI":"10.1056\/NEJM199612263352601"},{"doi-asserted-by":"publisher","unstructured":"32. Leyva F, Zegard A, Umar F, <i>et al<\/i>. Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy. Europace 2018; 20: 1804-12.","key":"32","DOI":"10.1093\/europace\/eux357"},{"doi-asserted-by":"crossref","unstructured":"33. Sugawara M, Kondo Y, Ryuzaki S, <i>et al<\/i>. Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy. J Cardiol 2024; 84: 170-6.","key":"33","DOI":"10.1016\/j.jjcc.2024.02.006"},{"doi-asserted-by":"publisher","unstructured":"34. Dauw J, Martens P, Nijst P, <i>et al<\/i>. The MADIT-ICD benefit score helps to select implantable cardioverter-defibrillator candidates in cardiac resynchronization therapy. Europace 2022; 24: 1276-83.","key":"34","DOI":"10.1093\/europace\/euac039"},{"doi-asserted-by":"crossref","unstructured":"35. Leyva F, Zegard A, Acquaye E, <i>et al<\/i>. Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy. J Am Coll Cardiol 2017; 70: 1216-27.","key":"35","DOI":"10.1016\/j.jacc.2017.07.712"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/2\/66_24-646\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T03:46:15Z","timestamp":1743824775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/2\/66_24-646\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.24-646","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"type":"print","value":"1349-2365"},{"type":"electronic","value":"1349-3299"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"article-number":"24-646"}}